Proton Pump Inhibitors and Risk of Cardiovascular Disease: A Self-Controlled Case Series Study.

Negative findings in the SCCS design suggest that association between increased cardiovascular risk and PPI, frequently reported in prior observational studies, is likely due to residual confounding related to conditions with PPI treatment, rather than a true relationship.